Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST)

Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012

Development and expansion of the IFOM-IEO campus

Prof Marco Foiani – University of Milan, Italy and Scientific Director IFOM
Development and expansion of the IFOM-IEO campus ( Prof Marco Foiani – University of Milan, Italy and Scientific Director IFOM )
9 Oct 2012

Histology and non-histology driven therapy for soft tissue sarcomas and the Rare Cancers Europe initiative

Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy
Histology and non-histology driven therapy for soft tissue sarcomas and the Rare Cancers Europe initiative ( Dr Paolo Casali – Instituto Nazionale Tumori, Milan, Italy )
9 Oct 2012

MET inhibitors for non-small cell lung cancer

Prof Georgio Scagliotti – University of Torino, Italy
MET inhibitors for non-small cell lung cancer ( Prof Georgio Scagliotti – University of Torino, Italy )
9 Oct 2012

Pathology and development of ovarian cancer

Dr Jamie Prat – Hospital De La Santa Creu I San Pau, Spain
Pathology and development of ovarian cancer ( Dr Jamie Prat – Hospital De La Santa Creu I San Pau, Spain )
9 Oct 2012

Putting the theory of personalised medicine into practice

Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard
Putting the theory of personalised medicine into practice ( Prof Fabrice Andre, Dr Ramesh Ramanathan, Prof Peter Harper and Prof Robert Leonard )
8 Oct 2012

Trametinib and dabrafenib combination therapy against metastatic melanoma

Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia
Trametinib and dabrafenib combination therapy against metastatic melanoma ( Dr Georgina Long – Westmead Hospital, The University of Sydney, Australia )
8 Oct 2012

Personalised cancer medicine and research: Today’s best practice

Prof José Baselga - Massachusetts General Hospital, Boston, USA
Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )
5 Oct 2012

Phase I study examining PI 3 kinase inhibitor for various tumours

Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012

Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib

Dr Tony Mok - Chinese University of Hong Kong
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib ( Dr Tony Mok - Chinese University of Hong Kong )
29 Sep 2012

iwNHL 10: Advances in the treatment of lymphoma

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Professor Michael Pfreundschuh - University of Saarland, Homburg-Saar, Germany; Prof John Gribben - Bart’s and Royal
iwNHL 10: Advances in the treatment of lymphoma ( Dr Wyndham Wilson -  National Cancer Institute, Bethesda, MD, USA;  Dr Myron Czuczman -  Roswell Park Cancer Institute, Buffalo, NY, USA;  Professor Michael Pfreundschuh - University of Saarland, Homburg-Saar, Germany; Prof John Gribben - Bart’s and Royal )
26 Sep 2012

Molecular stratification of breast cancer: reaching the clinic

Prof Carlos Caldas - University of Cambridge, UK
Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )
25 Jul 2012